In a bid to expand capacity and upgrade manufacturing facilities, Syngene International is planning to invest $200 million over the next two years.
The investment areas for the capital expenditure are research centre, formulation centre, manufacturing facilities and expansion of new capabilities. The company will tap a mixture of its own resources and debt to raise funds for future growth. Future funding requirements will be met through internal accruals and debt.
Syngene International offers discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 436.75 |
| Indegene | 482.00 |
| CMS Info Systems | 316.00 |
| JITF Infralogistics | 331.25 |
| Sagility | 42.27 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: